Table of Contents Executive Summary 1 Industry Overview of Rhinovirus Infections Drug 1.1 Definition of Rhinovirus Infections Drug 1.2 Rhinovirus Infections Drug Segment by Type 1.2.1 Global Rhinovirus Infections Drug Production Growth Rate Comparison by Types (2014-2025) 1.2.2 Cetylpyridinium Chloride 1.2.3 Human Rhinovirus (polyvalent) Vaccine 1.2.4 KR-22809 1.2.5 Others 1.3 Rhinovirus Infections Drug Segment by Applications 1.3.1 Global Rhinovirus Infections Drug Consumption Comparison by Applications (2014-2025) 1.3.2 Clinic 1.3.3 Hospital 1.3.4 Others 1.4 Global Rhinovirus Infections Drug Overall Market 1.4.1 Global Rhinovirus Infections Drug Revenue (2014-2025) 1.4.2 Global Rhinovirus Infections Drug Production (2014-2025) 1.4.3 North America Rhinovirus Infections Drug Status and Prospect (2014-2025) 1.4.4 Europe Rhinovirus Infections Drug Status and Prospect (2014-2025) 1.4.5 China Rhinovirus Infections Drug Status and Prospect (2014-2025) 1.4.6 Japan Rhinovirus Infections Drug Status and Prospect (2014-2025) 1.4.7 Southeast Asia Rhinovirus Infections Drug Status and Prospect (2014-2025) 1.4.8 India Rhinovirus Infections Drug Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Rhinovirus Infections Drug 2.3 Manufacturing Process Analysis of Rhinovirus Infections Drug 2.4 Industry Chain Structure of Rhinovirus Infections Drug 3 Development and Manufacturing Plants Analysis of Rhinovirus Infections Drug 3.1 Capacity and Commercial Production Date 3.2 Global Rhinovirus Infections Drug Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Rhinovirus Infections Drug 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Rhinovirus Infections Drug Production and Capacity Analysis 4.2 Rhinovirus Infections Drug Revenue Analysis 4.3 Rhinovirus Infections Drug Price Analysis 4.4 Market Concentration Degree 5 Rhinovirus Infections Drug Regional Market Analysis 5.1 Rhinovirus Infections Drug Production by Regions 5.1.1 Global Rhinovirus Infections Drug Production by Regions 5.1.2 Global Rhinovirus Infections Drug Revenue by Regions 5.2 Rhinovirus Infections Drug Consumption by Regions 5.3 North America Rhinovirus Infections Drug Market Analysis 5.3.1 North America Rhinovirus Infections Drug Production 5.3.2 North America Rhinovirus Infections Drug Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Rhinovirus Infections Drug Import and Export 5.4 Europe Rhinovirus Infections Drug Market Analysis 5.4.1 Europe Rhinovirus Infections Drug Production 5.4.2 Europe Rhinovirus Infections Drug Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Rhinovirus Infections Drug Import and Export 5.5 China Rhinovirus Infections Drug Market Analysis 5.5.1 China Rhinovirus Infections Drug Production 5.5.2 China Rhinovirus Infections Drug Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Rhinovirus Infections Drug Import and Export 5.6 Japan Rhinovirus Infections Drug Market Analysis 5.6.1 Japan Rhinovirus Infections Drug Production 5.6.2 Japan Rhinovirus Infections Drug Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Rhinovirus Infections Drug Import and Export 5.7 Southeast Asia Rhinovirus Infections Drug Market Analysis 5.7.1 Southeast Asia Rhinovirus Infections Drug Production 5.7.2 Southeast Asia Rhinovirus Infections Drug Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Rhinovirus Infections Drug Import and Export 5.8 India Rhinovirus Infections Drug Market Analysis 5.8.1 India Rhinovirus Infections Drug Production 5.8.2 India Rhinovirus Infections Drug Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Rhinovirus Infections Drug Import and Export 6 Rhinovirus Infections Drug Segment Market Analysis (by Type) 6.1 Global Rhinovirus Infections Drug Production by Type 6.2 Global Rhinovirus Infections Drug Revenue by Type 6.3 Rhinovirus Infections Drug Price by Type 7 Rhinovirus Infections Drug Segment Market Analysis (by Application) 7.1 Global Rhinovirus Infections Drug Consumption by Application 7.2 Global Rhinovirus Infections Drug Consumption Market Share by Application (2014-2019) 8 Rhinovirus Infections Drug Major Manufacturers Analysis 8.1 AIMM Therapeutics B.V. 8.1.1 AIMM Therapeutics B.V. Rhinovirus Infections Drug Production Sites and Area Served 8.1.2 AIMM Therapeutics B.V. Product Introduction, Application and Specification 8.1.3 AIMM Therapeutics B.V. Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Biological Mimetics, Inc. 8.2.1 Biological Mimetics, Inc. Rhinovirus Infections Drug Production Sites and Area Served 8.2.2 Biological Mimetics, Inc. Product Introduction, Application and Specification 8.2.3 Biological Mimetics, Inc. Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Biota Pharmaceuticals, Inc. 8.3.1 Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production Sites and Area Served 8.3.2 Biota Pharmaceuticals, Inc. Product Introduction, Application and Specification 8.3.3 Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Boehringer Ingelheim GmbH 8.4.1 Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production Sites and Area Served 8.4.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification 8.4.3 Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 Johnson & Johnson 8.5.1 Johnson & Johnson Rhinovirus Infections Drug Production Sites and Area Served 8.5.2 Johnson & Johnson Product Introduction, Application and Specification 8.5.3 Johnson & Johnson Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 Novartis AG 8.6.1 Novartis AG Rhinovirus Infections Drug Production Sites and Area Served 8.6.2 Novartis AG Product Introduction, Application and Specification 8.6.3 Novartis AG Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Theraclone Sciences, Inc. 8.7.1 Theraclone Sciences, Inc. Rhinovirus Infections Drug Production Sites and Area Served 8.7.2 Theraclone Sciences, Inc. Product Introduction, Application and Specification 8.7.3 Theraclone Sciences, Inc. Rhinovirus Infections Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 9 Development Trend of Analysis of Rhinovirus Infections Drug Market 9.1 Global Rhinovirus Infections Drug Market Trend Analysis 9.1.1 Global Rhinovirus Infections Drug Market Size (Volume and Value) Forecast 2019-2025 9.2 Rhinovirus Infections Drug Regional Market Trend 9.2.1 North America Rhinovirus Infections Drug Forecast 2019-2025 9.2.2 Europe Rhinovirus Infections Drug Forecast 2019-2025 9.2.3 China Rhinovirus Infections Drug Forecast 2019-2025 9.2.4 Japan Rhinovirus Infections Drug Forecast 2019-2025 9.2.5 Southeast Asia Rhinovirus Infections Drug Forecast 2019-2025 9.2.6 India Rhinovirus Infections Drug Forecast 2019-2025 9.3 Rhinovirus Infections Drug Market Trend (Product Type) 9.4 Rhinovirus Infections Drug Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Rhinovirus Infections Drug Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Rhinovirus Infections Drug Table Global Rhinovirus Infections Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025) Figure Global Rhinovirus Infections Drug Production Market Share by Types in 2018 Figure Cetylpyridinium Chloride Product Picture Figure Human Rhinovirus (polyvalent) Vaccine Product Picture Figure KR-22809 Product Picture Figure Others Product Picture Table Global Rhinovirus Infections Drug Consumption (K Pcs) Comparison by Applications (2014-2025) Figure Global Rhinovirus Infections Drug Consumption Market Share by Applications in 2018 Figure Clinic Figure Hospital Figure Others Figure Global Rhinovirus Infections Drug Revenue (Million USD) (2014-2025) Figure Global Rhinovirus Infections Drug Production (K Pcs) (2014-2025) Figure North America Rhinovirus Infections Drug Market Size (Million USD) (2014-2025) Figure Europe Rhinovirus Infections Drug Market Size (Million USD) (2014-2025) Figure China Rhinovirus Infections Drug Market Size (Million USD) (2014-2025) Figure Japan Rhinovirus Infections Drug Market Size (Million USD) (2014-2025) Figure Southeast Asia Rhinovirus Infections Drug Market Size (Million USD) (2014-2025) Figure India Rhinovirus Infections Drug Market Size (Million USD) (2014-2025) Table Rhinovirus Infections Drug Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Rhinovirus Infections Drug in 2018 Figure Manufacturing Process Analysis of Rhinovirus Infections Drug Figure Industry Chain Structure of Rhinovirus Infections Drug Table Capacity and Commercial Production Date of Key Manufacturers Table Global Rhinovirus Infections Drug Manufacturing Plants Distribution Table Rhinovirus Infections Drug Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Rhinovirus Infections Drug Capacity (K Pcs) of Major Manufacturers (2014-2019) Table Rhinovirus Infections Drug Production (K Pcs) of Major Manufacturers (2014-2019) Table Rhinovirus Infections Drug Production Market Share of Major Manufacturers (2014-2019) Figure Rhinovirus Infections Drug Production Share by Manufacturers in 2018 Table Rhinovirus Infections Drug Revenue (Million US$) of Major Manufacturers (2014-2019) Table Rhinovirus Infections Drug Revenue Market Share of Major Manufacturers (2014-2019) Figure Rhinovirus Infections Drug Revenue Share by Manufacturers in 2018 Table Rhinovirus Infections Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Rhinovirus Infections Drug Production by Regions 2014-2019 (K Pcs) Table Global Rhinovirus Infections Drug Production Market Share by Regions 2014-2019 Figure Global Rhinovirus Infections Drug Production Market Share by Regions in 2018 Table Global Rhinovirus Infections Drug Revenue by Regions 2014-2019 (Million USD) Table Global Rhinovirus Infections Drug Revenue Market Share by Regions 2014-2019 Figure Global Rhinovirus Infections Drug Revenue Market Share by Regions in 2018 Table Global Rhinovirus Infections Drug Consumption by Regions 2014-2019 (K Pcs) Table Global Rhinovirus Infections Drug Consumption Market Share by Regions 2014-2019 Figure North America Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs) Figure North America Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD) Table North America Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs) Figure Europe Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs) Figure Europe Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD) Table Europe Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs) Figure China Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs) Figure China Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD) Table China Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs) Figure Japan Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs) Figure Japan Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD) Table Japan Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs) Figure Southeast Asia Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs) Figure Southeast Asia Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs) Figure India Rhinovirus Infections Drug Production Growth Rate 2014-2019 (K Pcs) Figure India Rhinovirus Infections Drug Revenue Growth Rate 2014-2019 (Million USD) Table India Rhinovirus Infections Drug Production, Consumption Import and Export (K Pcs) Figure Global Consumption Rhinovirus Infections Drug Market Share by Application (2014-2019) Figure Global Value (Consumption) Rhinovirus Infections Drug Market Share by Application (2014-2019) Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Production Sites and Area Served Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Product Introduction, Application and Specification Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Production Growth Rate (2014-2019) Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Production Market Share (2014-2019) Figure AIMM Therapeutics B.V. Rhinovirus Infections Drug Revenue Market Share (2014-2019) Table AIMM Therapeutics B.V. Rhinovirus Infections Drug Main Business and Markets Served Table Biological Mimetics, Inc. Rhinovirus Infections Drug Production Sites and Area Served Table Biological Mimetics, Inc. Rhinovirus Infections Drug Product Introduction, Application and Specification Table Biological Mimetics, Inc. Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Biological Mimetics, Inc. Rhinovirus Infections Drug Production Growth Rate (2014-2019) Table Biological Mimetics, Inc. Rhinovirus Infections Drug Production Market Share (2014-2019) Figure Biological Mimetics, Inc. Rhinovirus Infections Drug Revenue Market Share (2014-2019) Table Biological Mimetics, Inc. Rhinovirus Infections Drug Main Business and Markets Served Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production Sites and Area Served Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Product Introduction, Application and Specification Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production Growth Rate (2014-2019) Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Production Market Share (2014-2019) Figure Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Revenue Market Share (2014-2019) Table Biota Pharmaceuticals, Inc. Rhinovirus Infections Drug Main Business and Markets Served Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production Sites and Area Served Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Product Introduction, Application and Specification Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production Growth Rate (2014-2019) Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Production Market Share (2014-2019) Figure Boehringer Ingelheim GmbH Rhinovirus Infections Drug Revenue Market Share (2014-2019) Table Boehringer Ingelheim GmbH Rhinovirus Infections Drug Main Business and Markets Served Table Johnson & Johnson Rhinovirus Infections Drug Production Sites and Area Served Table Johnson & Johnson Rhinovirus Infections Drug Product Introduction, Application and Specification Table Johnson & Johnson Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Johnson & Johnson Rhinovirus Infections Drug Production Growth Rate (2014-2019) Table Johnson & Johnson Rhinovirus Infections Drug Production Market Share (2014-2019) Figure Johnson & Johnson Rhinovirus Infections Drug Revenue Market Share (2014-2019) Table Johnson & Johnson Rhinovirus Infections Drug Main Business and Markets Served Table Novartis AG Rhinovirus Infections Drug Production Sites and Area Served Table Novartis AG Rhinovirus Infections Drug Product Introduction, Application and Specification Table Novartis AG Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Novartis AG Rhinovirus Infections Drug Production Growth Rate (2014-2019) Table Novartis AG Rhinovirus Infections Drug Production Market Share (2014-2019) Figure Novartis AG Rhinovirus Infections Drug Revenue Market Share (2014-2019) Table Novartis AG Rhinovirus Infections Drug Main Business and Markets Served Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Production Sites and Area Served Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Product Introduction, Application and Specification Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019) Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Production Growth Rate (2014-2019) Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Production Market Share (2014-2019) Figure Theraclone Sciences, Inc. Rhinovirus Infections Drug Revenue Market Share (2014-2019) Table Theraclone Sciences, Inc. Rhinovirus Infections Drug Main Business and Markets Served Figure Global Rhinovirus Infections Drug Production (K Pcs) Growth Rate Forecast 2019-2025 Figure Global Rhinovirus Infections Drug Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Rhinovirus Infections Drug Sales Price (USD/Pcs) Forecast 2019-2025 Figure North America Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure North America Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Europe Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure China Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Japan Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure Southeast Asia Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Rhinovirus Infections Drug Production Growth Rate Forecast 2019-2025 (K Pcs) Figure India Rhinovirus Infections Drug Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (K Pcs) of Rhinovirus Infections Drug by Type (2019-2025) Table Global Consumption (K Pcs) of Rhinovirus Infections Drug by Application (2019-2025) Table Rhinovirus Infections Drug Distributors List Table Rhinovirus Infections Drug Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AIMM Therapeutics B.V. Biological Mimetics, Inc. Biota Pharmaceuticals, Inc. Boehringer Ingelheim GmbH Johnson & Johnson Novartis AG Theraclone Sciences, Inc.